The increased secretion of the aforementioned pro-inflammatory cytokines results in the overactivation of inflammation-related signaling pathways in IBD patients, including the nuclear factor-kappa B (NF-κB) signaling pathway (39). This evidence concerns the gene NFKB1 and inflammatory bowel disease.